Home / Sweden / Moberg Pharma AB (publ)
Moberg Pharma AB (publ)
Short position disclosed on December 19, 2019.
0.83% of the capital sold short
1 disclosing funds
125 disclosures on record
SE0003613090 ISIN code
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
March 15, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors II LLC | 0.83% | unchanged | December 19, 2019 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 12, 2025 | Citadel Securities (Europe) Limited | 0.53% | still open |
| January 20, 2025 | GSA Capital Partners LLP | 0.55% | still open |
| January 16, 2025 | GSA Capital Partners LLP | 0.60% | still open |
| January 14, 2025 | GSA Capital Partners LLP | 0.50% | still open |
| September 17, 2024 | Citadel Securities (Europe) Limited | 0.59% | still open |
| June 28, 2024 | Quartys Limited | 0.56% | still open |
| June 17, 2024 | Quartys Limited | 0.90% | still open |
| June 14, 2024 | Quartys Limited | 1.00% | still open |
| June 13, 2024 | Quartys Limited | 1.28% | still open |
| June 11, 2024 | Quartys Limited | 1.75% | still open |
| June 7, 2024 | Quartys Limited | 1.25% | still open |
| June 5, 2024 | Quartys Limited | 0.98% | still open |
| June 4, 2024 | Quartys Limited | 0.56% | still open |
| September 1, 2023 | Philip Ohlsson | 0.58% | still open |
| September 30, 2020 | Nice & Green SA | 0.00% | still open |
| September 4, 2020 | Nice & Green SA | 0.89% | still open |
| August 18, 2020 | Nice & Green SA | 0.90% | still open |
| August 10, 2020 | Nice & Green SA | 0.82% | still open |
| July 20, 2020 | Nice & Green SA | 0.70% | still open |
| July 8, 2020 | Nice & Green SA | 0.60% | still open |
| July 6, 2020 | Nice & Green SA | 0.53% | still open |
| July 1, 2020 | Nice & Green SA | 0.00% | still open |
| June 25, 2020 | Nice & Green SA | 0.50% | still open |
| February 11, 2020 | Citadel Advisors LLC | 0.00% | still open |
| February 7, 2020 | Citadel Advisors LLC | 0.58% | still open |
| January 28, 2020 | Citadel Advisors LLC | 0.61% | still open |
| January 24, 2020 | Citadel Advisors LLC | 0.59% | still open |
| January 23, 2020 | Citadel Advisors LLC | 0.00% | still open |
| January 20, 2020 | Citadel Advisors LLC | 0.56% | still open |
| January 15, 2020 | Citadel Advisors LLC | 0.63% | still open |
| January 14, 2020 | Citadel Advisors LLC | 0.79% | still open |
| December 30, 2019 | Citadel Advisors LLC | 0.82% | still open |
| December 19, 2019 | Citadel Advisors II LLC | 0.83% | still open |
| December 18, 2019 | Citadel Advisors II LLC | 0.83% | still open |
| December 16, 2019 | Citadel Advisors II LLC | 0.79% | still open |
| December 15, 2019 | Citadel Advisors II LLC | 0.79% | still open |
| December 13, 2019 | Citadel Advisors II LLC | 0.50% | still open |
| December 12, 2019 | Citadel Advisors II LLC | 0.50% | still open |
| May 12, 2017 | Macquarie Funds Management Hong Kong Limited | 0.59% | still open |
| May 11, 2017 | Macquarie Funds Management Hong Kong Limited | 0.59% | still open |
| April 18, 2017 | Macquarie Funds Management Hong Kong Limited | 0.69% | still open |
| April 17, 2017 | Macquarie Funds Management Hong Kong Limited | 0.69% | still open |
| April 12, 2017 | Macquarie Funds Management Hong Kong Limited | 0.77% | still open |
| April 11, 2017 | Macquarie Funds Management Hong Kong Limited | 0.77% | still open |
| April 10, 2017 | WorldQuant, LLC | 0.56% | still open |
| April 9, 2017 | WorldQuant, LLC | 0.56% | still open |
| April 7, 2017 | Macquarie Funds Management Hong Kong Limited | 0.85% | still open |
| April 6, 2017 | Macquarie Funds Management Hong Kong Limited | 0.85% | still open |
| April 4, 2017 | Macquarie Funds Management Hong Kong Limited | 0.96% | still open |
| April 4, 2017 | WorldQuant, LLC | 0.69% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Moberg Pharma AB (publ), source Finansinspektionen, data as at December 19, 2019, https://www.quivad.com/action/moberg-pharma-ab-publ